- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
HDAC2 Antibody (C-term)Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP1102b | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
HDAC2 Antibody (C-term) - Product info | |
| Application | WB, IF, IHC
|
| Primary Accession | Q92769 |
| Reactivity | Human |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 55364 Da |
HDAC2 Antibody (C-term) - Additional info | |
| Gene ID 3066 | |
| Other Names HDAC2; Histone deacetylase 2 | |
| Target/Specificity This HDAC2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the C-terminal region of human HDAC2. | |
| Dilution WB~~1:100~500WB~~1:1000 IF~~1:10~50 IHC~~1:10~50 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions HDAC2 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
HDAC2 Antibody (C-term) - Protein Information | |
| Name HDAC2 | |
| Function Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Forms transcriptional repressor complexes by associating with MAD, SIN3, YY1 and N-COR. Interacts in the late S-phase of DNA-replication with DNMT1 in the other transcriptional repressor complex composed of DNMT1, DMAP1, PCNA, CAF1. Deacetylates TSHZ3 and regulates its transcriptional repressor activity. Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development | |
| Cellular Location Nucleus. | |
| Tissue Location Widely expressed; lower levels in brain and lung | |
HDAC2 Antibody (C-term) - Related products
AP1102b: HDAC2 Antibody (C-term)
AP9762c: HDAC2 Antibody (Center)
RI12420: HDAC2 predesign siRNA
BP1102b: HDAC2 Antibody (C-term) Blocking Peptide
BP9762c: HDAC2 Antibody (Center) Blocking Peptide
AJ1347a: Histone Deacetylase 2 Antibody (C-term)
HDAC2 Antibody (C-term) - Application data
-
Western blot analysis of HDAC2 (arrow) using rabbit polyclonal HDAC2 Antibody (C-term) (Cat.#AP1102b).293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected with the HDAC2 gene (Lane 2) (Origene Technologies).
-
Western blot analysis of anti-HDAC2 Antibody (C-term) (Cat.#AP1102b) in 293 cell line lysates (35ug/lane). HDAC2(arrow) was detected using the purified Pab.
-
Western blot analysis of anti-HDAC2 Antibody (C-term) (Cat.#AP1102b) in mouse spleen tissue lysates (35ug/lane). HDAC2(arrow) was detected using the purified Pab.
-
Confocal immunofluorescent analysis of HDAC2 Antibody (C-term)(Cat#AP1102b) with 293 cell followed by Alexa Fluor 488-conjugated goat anti-rabbit lgG (green).Actin filaments have been labeled with Alexa Fluor 555 phalloidin (red).
-
HDAC2 Antibody (C-term) (Cat. #AP1102b)immunohistochemistry analysis in formalin fixed and paraffin embedded human breast carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of HDAC2 Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.
-
Fluorescent confocal image of Hela cell stained with HDAC2 Antibody (C-term)(Cat#AP1102b).Hela cells were fixed with 4% PFA (20 min), permeabilized with Triton X-100 (0.1%, 10 min), then incubated with HDAC2 primary antibody (1:25, 1 h at 37℃). For secondary antibody, Alexa Fluor® 488 conjugated donkey anti-rabbit antibody (green) was used (1:400, 50 min at 37℃).Cytoplasmic actin was counterstained with Alexa Fluor® 555 (red) conjugated Phalloidin (7units/ml, 1 h at 37℃). Nuclei were counterstained with DAPI (blue) (10 µg/ml, 10 min). hHDAC2 immunoreactivity is localized to Nucleus significantly.
HDAC2 Antibody (C-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
Histone deacetylase 2 (HDAC2), or transcriptional regulator homolog RPD3 L1, is highly homologous to the yeast transcription factor RPD3 (reduced potassium dependency 3) gene. As in yeast, human HDA2 is likely to be involved in regulating chromatin structure during transcription. It has been implicated to associate with YY1, a mammalian zinc-finger transcription factor, which negatively regulates transcription by tethering RPD3 to DNA as a cofactor. This process is highly conserved from yeast to human.
REFERENCES
Choi, Y.B., et al., J. Biol. Chem. 279(49):50930-50941 (2004). Zhu, P., et al., Cancer Cell 5(5):455-463 (2004). Longworth, M.S., et al., J. Virol. 78(7):3533-3541 (2004). Lu, Y., et al., J. Biol. Chem. 278(48):47792-47802 (2003). Verdin, E., et al., Trends Genet. 19(5):286-293 (2003).